These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

789 related items for PubMed ID: 3524815

  • 1. Mutagenic and cell-transforming activities of triol-epoxides as compared to other chrysene metabolites.
    Glatt H, Seidel A, Bochnitschek W, Marquardt H, Marquardt H, Hodgson RM, Grover PL, Oesch F.
    Cancer Res; 1986 Sep; 46(9):4556-65. PubMed ID: 3524815
    [Abstract] [Full Text] [Related]

  • 2. Genotoxicity characteristics of reverse diol-epoxides of chrysene.
    Glatt H, Wameling C, Elsberg S, Thomas H, Marquardt H, Hewer A, Phillips DH, Oesch F, Seidel A.
    Carcinogenesis; 1993 Jan; 14(1):11-9. PubMed ID: 8425257
    [Abstract] [Full Text] [Related]

  • 3. Fjord- and bay-region diol-epoxides investigated for stability, SOS induction in Escherichia coli, and mutagenicity in Salmonella typhimurium and mammalian cells.
    Glatt H, Piée A, Pauly K, Steinbrecher T, Schrode R, Oesch F, Seidel A.
    Cancer Res; 1991 Mar 15; 51(6):1659-67. PubMed ID: 1900215
    [Abstract] [Full Text] [Related]

  • 4. Metabolic activation to a mutagen of 3-hydroxy-trans-7,8-dihydroxy-7,8-dihydrobenzo[a]pyrene, a secondary metabolite of benzo[a]pyrene.
    Glatt H, Seidel A, Ribeiro O, Kirkby C, Hirom P, Oesch F.
    Carcinogenesis; 1987 Nov 15; 8(11):1621-7. PubMed ID: 3311446
    [Abstract] [Full Text] [Related]

  • 5. Mutagenicity of the enantiomers of the diastereomeric bay-region benz(a)anthracene 3,4-diol-1,2-epoxides in bacterial and mammalian cells.
    Wood AW, Chang RL, Levin W, Yagi H, Thakker DR, van Bladeren PJ, Jerina DM, Conney AH.
    Cancer Res; 1983 Dec 15; 43(12 Pt 1):5821-5. PubMed ID: 6357432
    [Abstract] [Full Text] [Related]

  • 6. Bacterial and mammalian cell mutagenicity of four optically active bay-region 3,4-diol-1,2-epoxides and other derivatives of the nitrogen heterocycle dibenz[c,h]acridine.
    Wood AW, Chang RL, Levin W, Kumar S, Shirai N, Jerina DM, Lehr RE, Conney AH.
    Cancer Res; 1986 Jun 15; 46(6):2760-6. PubMed ID: 3516386
    [Abstract] [Full Text] [Related]

  • 7. Inhibitory effect of 3-hydroxybenzo(a)pyrene on the mutagenicity and tumorigenicity of (+/-)-7 beta, 8 alpha-dihydroxy-9 alpha, 10 alpha-epoxy-7,8,9,10-tetrahydrobenzo(a)pyrene.
    Huang MT, Wood AW, Chang RL, Yagi H, Sayer JM, Jerina DM, Conney AH.
    Cancer Res; 1986 Feb 15; 46(2):558-66. PubMed ID: 3079665
    [Abstract] [Full Text] [Related]

  • 8. Mutagenicity of the optical isomers of the diastereomeric bay-region chrysene 1,3-diol-3,4-epoxides in bacterial and mammalian cells.
    Wood AW, Chang RL, Levin W, Yagi H, Tada M, Vyas KP, Jerina DM, Conney AH.
    Cancer Res; 1982 Aug 15; 42(8):2972-6. PubMed ID: 7046912
    [Abstract] [Full Text] [Related]

  • 9. Mutagenicity and tumorigenicity of dihydrodiols, diol epoxides, and other derivatives of benzo(f)quinoline and benzo(h)quinoline.
    Kumar S, Sikka HC, Dubey SK, Czech A, Geddie N, Wang CX, LaVoie EJ.
    Cancer Res; 1989 Jan 01; 49(1):20-4. PubMed ID: 2908847
    [Abstract] [Full Text] [Related]

  • 10. Mutagenic potential of DNA adducts formed by diol-epoxides, triol-epoxides and the K-region epoxide of chrysene in mammalian cells.
    Phillips DH, Glatt HR, Seidel A, Bochnitschek W, Oesch F, Grover PL.
    Carcinogenesis; 1986 Oct 01; 7(10):1739-43. PubMed ID: 3757175
    [Abstract] [Full Text] [Related]

  • 11. Mutagenic activity of the 4,5- and 9,10-dihydrodiols of benzo[j]fluoranthene and their syn- and anti-dihydrodiol epoxides in Salmonella typhimurium.
    Marshall MV, He ZM, Weyand EH, Rice JE, LaVoie EJ.
    Environ Mol Mutagen; 1993 Oct 01; 22(1):34-45. PubMed ID: 8339723
    [Abstract] [Full Text] [Related]

  • 12. Mutagenicity of the enantiomers of the diastereomeric bay-region benzo(c)phenanthrene 3,4-diol-1,2-epoxides in bacterial and mammalian cells.
    Wood AW, Chang RL, Levin W, Thakker DR, Yagi H, Sayer JM, Jerina DM, Conney AH.
    Cancer Res; 1984 Jun 01; 44(6):2320-4. PubMed ID: 6372992
    [Abstract] [Full Text] [Related]

  • 13. Reactivity with DNA bases and mutagenicity toward Salmonella typhimurium of methylchrysene diol epoxide enantiomers.
    Melikian AA, Amin S, Huie K, Hecht SS, Harvey RG.
    Cancer Res; 1988 Apr 01; 48(7):1781-7. PubMed ID: 3258179
    [Abstract] [Full Text] [Related]

  • 14. Mutagenicity and cytotoxicity of benzo(a)pyrene benzo-ring epoxides.
    Wood AW, Wislocki PG, Chang RL, Levin W, Lu AY, Yagi J, Hernandez O, Herina DM, Conney AH.
    Cancer Res; 1976 Sep 01; 36(9 pt.1):3358-66. PubMed ID: 788899
    [Abstract] [Full Text] [Related]

  • 15. Mutagenicity of the bay-region diol-epoxides and other benzo-ring derivatives of dibenzo(a,h)pyrene and dibenzo(a,i)pyrene.
    Wood AW, Chang RL, Levin W, Ryan DE, Thomas PE, Lehr RE, Kumar S, Sardella DJ, Boger E, Yagi H, Sayer JM, Jerina DM, Conney AH.
    Cancer Res; 1981 Jul 01; 41(7):2589-97. PubMed ID: 7018665
    [Abstract] [Full Text] [Related]

  • 16. Species-specific enhancement by 7,8-benzoflavone of hepatic microsomal metabolism of benzo[e]pyrene 9,10-dihydrodiol to bay-region diol epoxides.
    Thakker DR, Levin W, Buening M, Yagi H, Lehr RE, Wood AW, Conney AH, Jerina DM.
    Cancer Res; 1981 Apr 01; 41(4):1389-96. PubMed ID: 7194138
    [Abstract] [Full Text] [Related]

  • 17. Mutagenicity of dihydrodiols and diol epoxides of dibenz[a, h]acridine in bacterial and mammalian cells.
    Wood AW, Chang RL, Katz M, Conney AH, Jerina DM, Sikka HC, Levin W, Kumar S.
    Cancer Res; 1989 Dec 15; 49(24 Pt 1):6981-4. PubMed ID: 2684405
    [Abstract] [Full Text] [Related]

  • 18. Multiple activation pathways of benzene leading to products with varying genotoxic characteristics.
    Glatt H, Padykula R, Berchtold GA, Ludewig G, Platt KL, Klein J, Oesch F.
    Environ Health Perspect; 1989 Jul 15; 82():81-9. PubMed ID: 2676505
    [Abstract] [Full Text] [Related]

  • 19. The formation of 9-hydroxychrysene-1,2-diol as an intermediate in the metabolic activation of chrysene.
    Hodgson RM, Seidel A, Bochnitschek W, Glatt HR, Oesch F, Grover PL.
    Carcinogenesis; 1985 Jan 15; 6(1):135-9. PubMed ID: 3967334
    [Abstract] [Full Text] [Related]

  • 20. Metabolism of benzo[c]chrysene and comparative mammary gland tumorigenesis of benzo[c]chrysene bay and fjord region diol epoxides in female CD rats.
    Amin S, Lin JM, Krzeminski J, Boyiri T, Desai D, El-Bayoumy K.
    Chem Res Toxicol; 2003 Feb 15; 16(2):227-31. PubMed ID: 12588194
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 40.